VOR vs ZURA

Vor Biopharma Inc. vs Zura Bio Limited — Valuation Comparison 2026

VOR

Biological Products, (No Diagnostic Substances)
Vor Biopharma Inc.
Quality
3.5
out of 10
Value Trap
30
LOW
Price
$14.97
Last close
Models
7/13
Active
VS

ZURA

Biological Products, (No Diagnostic Substances)
Zura Bio Limited
Quality
4.9
out of 10
Value Trap
12
SAFE
Price
$4.30
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType VOR Fair ValueVOR Upside ZURA Fair ValueZURA Upside
Bayesian DCF Intrinsic $6.33 -57.7% $2.56 -40.4%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $2.73 -80.8% $2.60 -39.6%
PWERM Option-Based $27.94 +86.6% $4.63 +7.6%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for VOR vs ZURA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

VOR vs ZURA — Which Stock Is More Undervalued?

ZURA scores higher with a 4.9/10 quality rating vs VOR's 3.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Vor Biopharma Inc. (VOR) and Zura Bio Limited (ZURA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

VOR currently trades at $14.97 with a QOC of 3.5/10, while ZURA trades at $4.30 with a QOC of 4.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).